Clinical Trial Update: Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring whether fisetin supplementation plus exercise can prevent frailty in breast cancer survivors (stages I–III, AJCC v8), currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fisetin (fisetin)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Status: RECRUITING